Skip to main content
Clinical Trials/JPRN-UMIN000023463
JPRN-UMIN000023463
Completed
未知

Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2Diabetes - Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2Diabetes

Dokkyo medical university hospital0 sites30 target enrollmentAugust 3, 2016
ConditionsType2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type2 diabetes
Sponsor
Dokkyo medical university hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2016
End Date
March 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients with hypersensitivity to the components of alogliptin or sulfonylurea. 2\)Patients with severe ketosis ,diabetic coma or pre coma. 3\)Patients with severe infection,before and after surgery,severe trauma. 4\)Patient with advanced renal dysfunction(eGFR\<30\) or patient on dialysis. 5\)Patients with severe liver dysfunction. 6\)Patients with pregnancy or possibility. 7\)Patients whom physician in charge considered inappropriate for study.

Outcomes

Primary Outcomes

Not specified

Similar Trials